Correspondence 0001193125-25-022716 from Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc.
Date: Feb. 7, 2025 · CIK: 0001999480 · Accession: 0001193125-25-022716
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284667
Letter
ALTO NEUROSCIENCE, INC.
650 Castro Street, Suite 450
Mountain View, California 94041
February 7,
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Daniel Crawford
Re: Alto Neuroscience, Inc.
Registration Statement on Form S-3 (File No. 333-284667)
Request for Acceleration of Effective Date
Daniel Crawford:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284667) (the “Registration Statement”) to become effective on February 11, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. The Registrant hereby authorizes each of Courtney M.W. Tygesson and Madison A. Jones of Cooley LLP to make such a request on its behalf.
Once the Registration Statement has been declared effective, please confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680 or ctygesson@cooley.com, or in her absence, Madison A. Jones at (202) 728-7087 or madison.jones@cooley.com.
[Signature page follows]
Very truly yours,
Alto Neuroscience, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP ALTO NEUROSCIENCE, INC. 650 Castro Street, Suite 450 Mountain View, California 94041 February 7, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Daniel Crawford Re: Alto Neuroscience, Inc. Registration Statement on Form S-3 (File No. 333-284667) Request for Acceleration of Effective Date Daniel Crawford: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284667) (the “Registration Statement”) to become effective on February 11, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. The Registrant hereby authorizes each of Courtney M.W. Tygesson and Madison A. Jones of Cooley LLP to make such a request on its behalf. Once the Registration Statement has been declared effective, please confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680 or ctygesson@cooley.com, or in her absence, Madison A. Jones at (202) 728-7087 or madison.jones@cooley.com. [Signature page follows] Very truly yours, Alto Neuroscience, Inc. By: /s/ Nicholas Smith Nicholas Smith Chief Financial Officer cc: Amit Etkin, Alto Neuroscience, Inc. Erin McQuade, Alto Neuroscience, Inc. Divakar Gupta, Cooley LLP Christina Roupas, Cooley LLP Courtney M.W. Tygesson, Cooley LLP Madison A. Jones, Cooley LLP Signature Page to Company Acceleration Request – S-3